109 related articles for article (PubMed ID: 31647315)
1. In Silico Identification of Potential Inhibitors of the Wnt Signaling Pathway in Human Breast Cancer.
Alves Pinto I; Freitas Da Silveira NJ
J Comput Biol; 2020 Jul; 27(7):999-1010. PubMed ID: 31647315
[TBL] [Abstract][Full Text] [Related]
2. A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.
Xie W; Zhang Y; He Y; Zhang K; Wan G; Huang Y; Zhou Z; Huang G; Wang J
Int J Biochem Cell Biol; 2018 Oct; 103():45-55. PubMed ID: 30096373
[TBL] [Abstract][Full Text] [Related]
3. A novel humanized Frizzled-7-targeting antibody enhances antitumor effects of Bevacizumab against triple-negative breast cancer via blocking Wnt/β-catenin signaling pathway.
Xie W; Zhao H; Wang F; Wang Y; He Y; Wang T; Zhang K; Yang H; Zhou Z; Shi H; Wang J; Huang G
J Exp Clin Cancer Res; 2021 Jan; 40(1):30. PubMed ID: 33436039
[TBL] [Abstract][Full Text] [Related]
4. Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled.
Lee HJ; Bao J; Miller A; Zhang C; Wu J; Baday YC; Guibao C; Li L; Wu D; Zheng JJ
J Biol Chem; 2015 Dec; 290(51):30596-606. PubMed ID: 26504084
[TBL] [Abstract][Full Text] [Related]
5. Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells.
Riley RS; Day ES
Small; 2017 Jul; 13(26):. PubMed ID: 28544579
[TBL] [Abstract][Full Text] [Related]
6. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes.
Zarei N; Fazeli M; Mohammadi M; Nejatollahi F
Breast Cancer Res Treat; 2018 Jun; 169(3):427-436. PubMed ID: 29411237
[TBL] [Abstract][Full Text] [Related]
7. Developing and characterization of single chain variable fragment (scFv) antibody against frizzled 7 (Fzd7) receptor.
Nickho H; Younesi V; Aghebati-Maleki L; Motallebnezhad M; Majidi Zolbanin J; Movassagh Pour A; Yousefi M
Bioengineered; 2017 Sep; 8(5):501-510. PubMed ID: 27849134
[TBL] [Abstract][Full Text] [Related]
8. Wnt Signaling in Cancer: Not a Binary ON:OFF Switch.
Flanagan DJ; Vincan E; Phesse TJ
Cancer Res; 2019 Dec; 79(23):5901-5906. PubMed ID: 31431458
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Wnt pathway component expression in breast and colorectal cancer.
Michelli M; Zougros A; Chatziandreou I; Michalopoulos NV; Lazaris AC; Saetta AA
Pathol Res Pract; 2020 Jul; 216(7):153005. PubMed ID: 32534708
[TBL] [Abstract][Full Text] [Related]
10. Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling.
Koval AV; Vlasov P; Shichkova P; Khunderyakova S; Markov Y; Panchenko J; Volodina A; Kondrashov FA; Katanaev VL
Biochem Pharmacol; 2014 Feb; 87(4):571-8. PubMed ID: 24355563
[TBL] [Abstract][Full Text] [Related]
11. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
12. A vanillin derivative suppresses the growth of HT29 cells through the Wnt/β-catenin signaling pathway.
Ma W; Li X; Song P; Zhang Q; Wu Z; Wang J; Li X; Xu R; Zhao W; Liu Y; Liu H; Yao X; Tang X; Chen P
Eur J Pharmacol; 2019 Apr; 849():43-49. PubMed ID: 30707959
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Klotho peptide antagonists against Wnt3 and Wnt3a target proteins using combination of protein engineering, protein-protein docking, peptide docking and molecular dynamics simulations.
Mirza SB; Ekhteiari Salmas R; Fatmi MQ; Durdagi S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):84-98. PubMed ID: 27766889
[TBL] [Abstract][Full Text] [Related]
14.
Flanagan DJ; Barker N; Costanzo NSD; Mason EA; Gurney A; Meniel VS; Koushyar S; Austin CR; Ernst M; Pearson HB; Boussioutas A; Clevers H; Phesse TJ; Vincan E
Cancer Res; 2019 Mar; 79(5):970-981. PubMed ID: 30622113
[TBL] [Abstract][Full Text] [Related]
15. RSPO2 suppresses colorectal cancer metastasis by counteracting the Wnt5a/Fzd7-driven noncanonical Wnt pathway.
Dong X; Liao W; Zhang L; Tu X; Hu J; Chen T; Dai X; Xiong Y; Liang W; Ding C; Liu R; Dai J; Wang O; Lu L; Lu X
Cancer Lett; 2017 Aug; 402():153-165. PubMed ID: 28600110
[TBL] [Abstract][Full Text] [Related]
16. γ-Tocotrienol reversal of epithelial-to-mesenchymal transition in human breast cancer cells is associated with inhibition of canonical Wnt signalling.
Ahmed RA; Alawin OA; Sylvester PW
Cell Prolif; 2016 Aug; 49(4):460-70. PubMed ID: 27323693
[TBL] [Abstract][Full Text] [Related]
17. LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer.
Pan L; Chen X; Fu S; Yu W; Li C; Wang T; Lo HW; Lin J
Breast Cancer Res Treat; 2020 May; 181(1):31-41. PubMed ID: 32240456
[TBL] [Abstract][Full Text] [Related]
18. FZD7 has a critical role in cell proliferation in triple negative breast cancer.
Yang L; Wu X; Wang Y; Zhang K; Wu J; Yuan YC; Deng X; Chen L; Kim CC; Lau S; Somlo G; Yen Y
Oncogene; 2011 Oct; 30(43):4437-46. PubMed ID: 21532620
[TBL] [Abstract][Full Text] [Related]
19. Preferential Inhibition of Wnt/β-Catenin Signaling by Novel Benzimidazole Compounds in Triple-Negative Breast Cancer.
Gangrade A; Pathak V; Augelli-Szafran CE; Wei HX; Oliver P; Suto M; Buchsbaum DJ
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783777
[TBL] [Abstract][Full Text] [Related]
20. Dual inhibition of Wnt and Yes-associated protein signaling retards the growth of triple-negative breast cancer in both mesenchymal and epithelial states.
Sulaiman A; McGarry S; Li L; Jia D; Ooi S; Addison C; Dimitroulakos J; Arnaout A; Nessim C; Yao Z; Ji G; Song H; Gadde S; Li X; Wang L
Mol Oncol; 2018 Apr; 12(4):423-440. PubMed ID: 29316250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
